Reta Vial - BioHack London

Reta Vial 10mg - BioHack London

Disclaimer: This product is intended for laboratory research use only. Not for human consumption.

Retatrutide is a research‑grade peptide engineered to engage three key metabolic hormone receptors — glucagon‑like peptide‑1 (GLP‑1), glucose‑dependent insulinotropic polypeptide (GIP), and glucagon receptors — simultaneously. This triple agonist profile distinguishes it from single‑ and dual‑agonist compounds and makes it a useful tool in laboratory investigations of complex metabolic regulation, energy balance mechanisms, and peptide‑receptor interactions.

Designed originally for clinical development in metabolic disorders, retatrutide is not approved for human use, and products labelled as research materials are supplied strictly for in‑vitro or preclinical experimentation.

Key Features

• Triple receptor agonist targeting GLP‑1, GIP, and glucagon receptors
• Research peptide for in‑vitro and mechanistic studies
• 99% purity, lab‑verified
• Supplied as a lyophilised powder
• Unit size: 10 mg per vial

Handling & Storage

After reconstitution (mixed with bacteriostatic water):

• Store in a refrigerator (2–8°C).
• Do not freeze once reconstituted.
• Use within 30–45 days for most peptides.

Who Should Use?

This product is strictly intended for use by:

• Qualified scientific researchers
• Laboratory personnel
• Healthcare professionals involved in metabolic research

About Retatrutide in Research
Retatrutide is employed in laboratory research to explore signalling mechanisms relevant to metabolic pathways — including insulin sensitivity, receptor binding profiles, and peptide cross‑activity. Its triple agonist activity supports investigation into multi‑receptor modulation and energy balance circuits under controlled experimental conditions. 

Synthesis & Quality
Manufactured via validated peptide synthesis processes, each batch of retatrutide undergoes stringent identity and purity checks to ensure reproducibility and lot‑to‑lot consistency. Certificates of Analysis (CoA) are available upon request.

Legal & Safety
Supplied strictly for laboratory research. Not approved by regulatory agencies such as the FDA for clinical or human use. Products are not medicines, supplements, foods, or cosmetics. Researchers are responsible for compliance with institutional and local safety policies.

External Resources for Researchers

• PubMed — Retatrutide peptide (search)
• Google Scholar — Retatrutide research overview

For inquiries or support, contact Info@BioHackLondon.com/